Abraxane (paclitaxel albumin-bound)
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Abraxane (paclitaxel albumin-bound), covering 2017-08-31 to 2023-07-17. Get the full timeline:
Most recent: Clinical Trial Update: Sitagliptin Combined With Gemcitabine and Albumin-bound Paclitaxel in PDAC Patients [Phase 2]